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chondrogenic phenotype of the MSC was assessed following short-term
(1 week) culture.
Results: Addition of rAC to the culture media of rat articular chondrocytes
led to elevated expression of Sox-9, collagen IIA1, FGF2, TGF beta-1 and
several other chondrogenic markers. Similar results were obtained for
cells grown in monolayer cultures or 3-D collagen scaffolds. Elevated
Sox-9 and collagen IIA1 expression also was observed following rAC
treatment of human chondrocytes from a patient with osteoarthritis. No
changes in the total cell numbers were observed despite these positive
changes in the chondrogenic phenotype, indicating that the primary
effect of rAC was on the differentiation capacity of the cells, rather than
on cell survival. We also evaluated the effect of rAC on rat bone marrow
grown for 1 week, and found that the number of MSC in these cultures
was increased ~2–3-fold as assessed by colony forming units (CFU-F) and
ﬂow cytometry, and that their chondrogenic phenotype was positively
inﬂuenced as well.
Conclusions: Based on these results we suggest that AC is an important
enzyme required to maintain the differentiated phenotype of primary
chondrocytes, and that supplementation of media with rAC results in
improved chondrocyte quality following ex vivo expansion. rAC also
improves the yield of bone marrow-derived MSC from short-term
cultures, and their chondrogenic phenotype as well. rAC may therefore
be an important reagent that can be used to improve the production
of chondrocytes for cartilage repair, either ex vivo or through direct
administration to damaged cartilage sites.
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Purpose: Articular cartilage injury remains one of the major concerns
in orthopaedic surgery. Although the repair process of articular cartilage
defects has been studied in many species. The extent and time course of
articular cartilage defect healing in humans are not well described.
Mesenchymal stem cells (MSCs) are an important cell source for cartilage
regeneration. A number of successful results in transplantation MSCs into
cartilage defects have been reported in animal models. However, Clinical
studies of MSCs transplantation for cartilage repair were very few.
Physicians not much know efﬁcacy and safety of MSCs transplantation
for cartilage repair in clinical.
Evaluation of the status of articular cartilage repair and MSCs
transplantation for articular cartilage repair at different time points in
a primate model may provide a healing process, efﬁcacy, safety and
postoperative activity recommendations in clinical.
Methods: Full-thickness osteochondral defects were created on the
medial femoral condyles(5mm in diameters and 5mm in depth) and
trochlea(3mm in diameters and 5mm in depth) of 18 cynomolgus
macaques, and the animals were divided into three groups: MSC, Gel,
and Defect. In the MSC group, the defects were ﬁlled with bone marrow-
derived MSCs embedded in collagen gel. In the Gel group, the defects
were ﬁlled with collagen gel without cells. In the Defect group, the
defects were left empty and additional defect were created on the lateral
femoral condyles(2mm in diameters and 5mm in depth). All groups were
evaluated by gross and histologic examination at 6-, 12- and 24-weeks.
Results: In the defect group, Cartilaginous repair responses failed to
occur in the lager 3mm defects, which was covered only by ﬁbrous scar
tissue. In contrast, hyaline-like articular cartilage was regenerated by
24 weeks in 2mm defects. In the MSC group, the border between bone
and cartilage moved upwards, integrations between native cartilage and
regenerated tissue were improved. After 24 weeks, histological scores
of the MSC group improved and were better than those of two other
control groups.
Conclusions: 2mm diameter full-thickness cartilage defect whose size
were critical for primate knees. In the primate animal model, signiﬁcant
improvements in the extent and quality of cartilage repair were observed
from the 12- to 24-week time points after transplantation of MSCs.
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OSTEOARTHRITIC PATIENTS
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1Univ. Med. and Pharmacy, Iasi, Romania; 2REMEDI NUI, Galway, Ireland
Purpose: To asses the presence and biological potential of stem
cells in three mesehchymal tissues (subchondral bone, synovial layer,
periarticular adipose tissue) in late stages osteoarthritic patients, subjects
of total knee replacement (TKR)
Methods: Samples were collected from patients undergoing TKR, plastic
adherent cells cultured in complete aMEM with FGF b for succesive
passages: cell morphology and growth potential was recorded. Flow
cytometric surface cell markers detection for stemness antibodies
was performed. Differentiation assays for three mesenchymal lineages
(osteogenesis adipogenesis chondrogenesis) was assesed by qualitative
and quantitative method. Time lapse life cell imaging of nondiferentiated
cells over 24 hours period was used to determine cell kinetics.
Results: Mesenchymal cells derived from all donors and tissue types
displayed morphology and growth potential of MSCs, were positive
for stemness related antibodies (CD 105, CD 73, CD 90), underwent
differentiation toward three lineages with signiﬁcant differences
between tissue of origin and not between donors. Cell kinetics, recorded
for one donor, was different for adipose derived, synovial derived and
trabecular bone derived MSCs, a paralel could be made between growth
kinetics and recorded cell speed.
Conclusions: Late stage OA derived human tissues (subchondral
trabecular bone, extraarticular adipose tissue and synovial layer
contain phenotypically different MSCs which have different growth and
differentiation potential which could be related with the pathogeny
and progression of OA, further to be investigated; these tissues can be
conssidered as cell source for regenerative therapies.
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Purpose: Articular cartilage lacks the essential components for self-
repair, often resulting in inadequate healing of isolated cartilage
injury, which can lead to degenerative osteoarthritis (OA). Designing
techniques to improve cartilage repair after injury may prevent or
delay development of OA. Bone marrow-derived mesenchymal stem cells
(MSC) are a promising cell source for articular cartilage regeneration. In
vitro, MSC have been shown to undergo chondrogenic differentiation
in the presence of transforming growth factor b1 (TGF-b1), via a
signaling pathway known to play a key regulatory role in chondrogenesis.
Various knockout studies suggest that the TGF-b type II receptor
(TbR-II) is speciﬁcally important in skeletal muscle formation and
bone morphogenesis, but its role has not been clearly deﬁned in
chondrogenesis. The purpose of this study is to test the hypothesis
that levels of TbR-II can predict the cellular responsiveness of equine
bone marrow-derived MSC to TGF-b1 and are related to subsequent
chondrogenic potential.
Methods: Bone marrow aspirate was collected from the sternum of 9
horses and MSC were isolated and expanded in culture until passage
two. To evaluate chondrogenesis, equine MSC were cultured as pellets in
chondrogenic medium with or without addition of TGF-b1 (10ng/ml).
At Day 21, pellets were collected and pellet area was measured
using a stereomicroscope. Pellets were parafﬁn-embedded, sectioned
and stained with safranin-O/fast green for sulfated glycosaminoglycans
(GAG). The Bern score was used for histological grading with a
higher score indicating higher chondrogenesis. Presence of TbR-II was
analyzed by immunoﬂuorescence (K105, Cell Signaling Technology) and
ﬁve to seven regions of each pellet were imaged with ﬂuorescence
microscopy at 40X. The TbR-II intensity of each region was quantiﬁed
with Visiopharm image analysis software and normalized to the
number of cells. Comparisons between groups were performed using
paired t-tests and correlations were evaluated by Pearson’s correlation.
Statistical analysis was performed using SPSS and p< 0.05 was considered
signiﬁcant.
